Risk of postoperative complications in rheumatoid arthritis relevant to treatment with biologic agents: A report from the Committee on Arthritis of the Japanese Orthopaedic Association

Journal of Orthopaedic Science

Volumn 16, Issue 6, 2011, Pages 778-784

  Suzuki, Masahiko ^a   Nishida, Keiichiro ^a,b   Soen, Satoshi ^a,c   Oda, Hiromi ^a,d   Inoue, Hiroshi ^a,e   Kaneko, Atsushi ^a,f   Takagishi, Kenji ^a,g   Tanaka, Takaaki ^a,h   Matsubara, Tsukasa ^a,i   Mitsugi, Naoto ^a,j   Mochida, Yuichi ^a,j   Momohara, Shigeki ^a,k   Mori, Toshihito ^a,l   Suguro, Toru ^a,m  

^a Committee on Arthritis of the Japanese Orthopaedic Association ^*  (Japan)

^b OKAYAMA UNIVERSITY   (Japan)

^c KINDAI UNIVERSITY NARA HOSPITAL   (Japan)

^d SAITAMA MEDICAL UNIVERSITY   (Japan)

^e Inoue Hospital   (Japan)

^f NATIONAL HOSPITAL ORGANIZATION NAGOYA MEDICAL CENTER   (Japan)

^g GUNMA UNIVERSITY   (Japan)

^h Tanaka Orthopaedic Hospital   (Japan)

ⁱ Matsubara Mayflower Hospital   (Japan)

^j YOKOHAMA CITY UNIVERSITY MEDICAL CENTER   (Japan)

^k TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^l NATIONAL HOSPITAL ORGANIZATION   (Japan)

^m TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; ADALIMUMAB; ANTIRHEUMATIC AGENT; CORTICOSTEROID DERIVATIVE; ETANERCEPT; INFLIXIMAB; METHOTREXATE; TACROLIMUS; TOCILIZUMAB;

ADULT; AGED; ARTHROPLASTY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PREVALENCE; RHEUMATOID ARTHRITIS; SURGICAL TECHNIQUE; TEACHING HOSPITAL; THROMBOSIS; WOUND HEALING IMPAIRMENT;

EID: 83055194524     PISSN: 09492658     EISSN: 14362023     Source Type: Journal    
DOI: 10.1007/s00776-011-0142-3     Document Type: Article

References (35)

1. Lipsky PE, van der Heijde DM, St Clair EW, Furst DE, Breedveld FC, Kalden JR, Smolen JS, Weisman M, Emery P, Feldmann M, Harriman GR, Maini RN, Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group. Infliximab and methotrexate in the treatment of rheumatoid arthritis. N Engl J Med. 2000;343:1594-602. (Pubitemid 32162982)
2. LW Moreland MH Schiff SW Baumgartner EA Tindall RM Fleischmann KJ Bulpitt AL Weaver EC Keystone DE Furst PJ Mease EM Ruderman DA Horwitz DG Arkfeld L Garrison DJ Burge CM Blosch ML Lange ND McDonnell ME Weinblatt 1999 Etanercept therapy in rheumatoid arthritis: a randomized, controlled trial Ann Intern Med 130 478 486 10075615 1:CAS:528:DyaK1MXitFChs7Y%3D (Pubitemid 29135800)
3. ME Weinblatt EC Keystone DE Furst LW Moreland MH Weisman CA Birbara LA Teoh SA Fischkoff EK Chartash 2003 Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial Arthritis Rheum 48 35 45 12528101 1:CAS:528:DC%2BD3sXhtFGnsb0%3D (Pubitemid 36091645)
4. N Nishimoto J Hashimoto N Miyasaka K Yamamoto S Kawai T Takeuchi N Murata D van der Heijde T Kishimoto 2007 Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab Ann Rheum Dis 66 1162 1167 17485422 1:CAS:528:DC%2BD2sXhtVKltL7O (Pubitemid 47309731)
5. Y Kadono H Yasunaga H Horiguchi H Hashimoto S Matsuda S Tanaka K Nakamura 2010 Statistics for orthopedic surgery 2006-2007: data from the Japanese diagnosis procedure combination database J Orthop Sci 15 162 170 20358327
6. SM Kurtz KL Ong E Lau KJ Bozic D Berry J Parvizi 2010 Prosthetic joint infection risk after TKA in the Medicare population Clin Orthop Relat Res 468 52 56 19669386
7. H Dale G Hallan B Espehaug LI Havelin LB Engesaeter 2009 Increasing risk of revision due to deep infection after hip arthroplasty Acta Orthop 80 639 645 19995313
8. T Bongartz CS Halligan DR Osmon MS Reinalda WR Bamlet CS Crowson 2008 Incidence and risk factors of prosthetic joint infection after total hip or knee replacement in patients with rheumatoid arthritis Arthritis Rheum 59 1713 1720 19035425
9. E Jämsen H Huhtala T Puolakka T Moilanen 2009 Risk factors for infection after knee arthroplasty. A register-based analysis of 43, 149 cases J Bone Joint Surg Am 91 38 47 19122077
10. T Koike M Harigai S Inokuma K Inoue N Ishiguro J Ryu T Takeuchi Y Tanaka H Yamanaka K Fujii B Freundlich M Suzukawa 2009 Postmarketing surveillance of the safety and effectiveness of etanercept in Japan J Rheumatol 36 898 906 19332630 1:CAS:528:DC%2BD1MXmtV2iurw%3D
11. T Takeuchi Y Tatsuki Y Nogami N Ishiguro Y Tanaka H Yamanaka N Kamatani M Harigai J Ryu K Inoue H Kondo S Inokuma T Ochi T Koike 2008 Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis Ann Rheum Dis 67 189 194 17644554 1:CAS:528: DC%2BD1cXisFCqtrg%3D (Pubitemid 351183307)
12. FED-STD-209E Federal standard airborne particulate cleanliness classes in cleanrooms and clean. Federal supply service, GSA; 1992.
13. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR, Hospital Infection Control Practices Advisory Committee. Guideline for prevention of surgical site infection, 1999. Infect Control Hosp Epidemiol. 1999;20:250-78, Quiz 279-80.
14. C Bibbo JW Goldberg 2004 Infectious and healing complications after elective orthopaedic foot and ankle surgery during tumor necrosis factor-alpha inhibition therapy Foot Ankle Int 25 331 335 15134615 (Pubitemid 39096154)
15. AA den Broeder MC Creemers J Fransen E de Jong DJ de Rooij A Wymenga M Waal-Malefijt FH van den Hoogen 2007 Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study J Rheumatol 34 689 695 (Pubitemid 46641372)
16. JT Giles SJ Bartlett AC Gelber S Nanda K Fontaine V Ruffing JM Bathon 2006 Tumor necrosis factor inhibitor therapy and risk of serious postoperative orthopedic infection in rheumatoid arthritis Arthritis Rheum 55 333 337 16583385
17. Y Hirano T Kojima Y Kanayama T Shioura M Hayashi D Kida A Kaneko Y Eto N Ishiguro 2010 Influences of anti-tumour necrosis factor agents on postoperative recovery in patients with rheumatoid arthritis Clin Rheumatol 29 495 500 20069328
18. K Kawakami K Ikari K Kawamura S Tsukahara T Iwamoto K Yano Y Sakuma A Tokita S Momohara 2010 Complications and features after joint surgery in rheumatoid arthritis patients treated with tumour necrosis factor-alpha blockers: perioperative interruption of tumour necrosis factor-alpha blockers decreases complications? Rheumatology 49 341 347 19965973 1:CAS:528: DC%2BC3cXntleqsw%3D%3D
19. A Ruyssen-Witrand L Gossec C Salliot M Luc M Duclos S Guignard M Dougados 2007 Complication rates of 127 surgical procedures performed in rheumatic patients receiving tumor necrosis factor alpha blockers Clin Exp Rheumatol 25 430 436 17631740 1:STN:280:DC%2BD2svhtlagtw%3D%3D (Pubitemid 47091020)
20. SC Talwalkar DM Grennan J Gray P Johnson MJ Hayton 2005 Tumour necrosis factor alpha antagonists and early postoperative complications in patients with inflammatory joint disease undergoing elective orthopaedic surgery Ann Rheum Dis 64 650 651 15769927 1:STN:280:DC%2BD2M7jslGgsQ%3D%3D (Pubitemid 40469105)
21. D Wendling JC Balblanc A Brousse A Lohse G Lehuede P Garbuio E Toussirot B Auge D Jacques 2005 Surgery in patients receiving anti-tumour necrosis factor alpha treatment in rheumatoid arthritis: an observational study on 50 surgical procedures Ann Rheum Dis 64 1378 1379 16100348 1:STN:280:DC%2BD2MvjtFKnsw%3D%3D (Pubitemid 41206266)
22. M Hirao J Hashimoto H Tsuboi A Nampei H Nakahara N Yoshio T Mima H Yoshikawa N Nishimoto 2009 Laboratory and febrile features after joint surgery in patients with rheumatoid arthritis treated with tocilizumab Ann Rheum Dis 68 654 657 18519424 1:CAS:528:DC%2BD1MXls1ChurY%3D
23. EF Berbari DR Osmon MC Duffy RN Harmssen JN Mandrekar AD Hanssen JM Steckelberg 2006 Outcome of prosthetic joint infection in patients with rheumatoid arthritis: the impact of medical and surgical therapy in 200 episodes Clin Infect Dis 42 216 223 16355332 (Pubitemid 43054193)
24. G Peersman R Laskin J Davis M Peterson 2001 Infection in total knee replacement: a retrospective review of 6489 total knee replacements Clin Orthop Relat Res 392 15 23 11716377 (Pubitemid 33054925)
25. SL Bridges Jr A Lopez-Mendez KH Han IC Tracy GS Alarcon 1991 Should methotrexate be discontinued before elective orthopedic surgery in patients with rheumatoid arthritis? J Rheumatol 18 984 988 1920333
26. DM Grennan J Gray J Loudon S Fear 2001 Methotrexate and early postoperative complications in patients with rheumatoid arthritis undergoing elective orthopaedic surgery Ann Rheum Dis 60 214 217 11171680 1:CAS:528:DC%2BD3MXit1elsL0%3D (Pubitemid 32260601)
27. A Jain M Witbreuk C Ball J Nanchahal 2002 Influence of steroids and methotrexate on wound complications after elective rheumatoid hand and wrist surgery J Hand Surg Am 27 449 455 12015719 (Pubitemid 34522572)
28. K Murata T Yasuda H Ito M Yoshida M Shimizu T Nakamura 2006 Lack of increase in postoperative complications with low-dose methotrexate therapy in patients with rheumatoid arthritis undergoing elective orthopedic surgery Mod Rheumatol 16 14 19 16622718 1:CAS:528:DC%2BD28Xhs12hu78%3D
29. R Koike T Takeuchi K Eguchi N Miyasaka 2007 Update on the Japanese guidelines for the use of infliximab and etanercept in rheumatoid arthritis Mod Rheumatol 17 451 458 18084695 1:CAS:528:DC%2BD1cXisFCjtbo%3D
30. R Koike M Harigai T Atsumi K Amano S Kawai K Saito T Saito M Yamamura T Matsubara N Miyasaka 2009 Japan College of Rheumatology 2009 guidelines for the use of tocilizumab, a humanized anti-interleukin-6 receptor monoclonal antibody, in rheumatoid arthritis Mod Rheumatol 19 351 357 19590933 1:CAS:528: DC%2BD1MXptlOgsrc%3D
31. LM Ellis EM Copeland 3rd WW Souba 1991 Perioperative nutritional support Surg Clin North Am 71 493 507 1904639 1:STN:280:DyaK3M3mt1yjtQ%3D%3D
32. R Latham AD Lancaster JF Covington JS Pirolo CS Thomas 2001 The association of diabetes and glucose control with surgical-site infections among cardiothoracic surgery patients Infect Control Hosp Epidemiol 22 607 612 11776345 1:STN:280:DC%2BD38%2FkvVyjug%3D%3D (Pubitemid 33152102)
33. SF Mishriki DJ Law PJ Jeffery 1990 Factors affecting the incidence of postoperative wound infection J Hosp Infect 16 223 230 1979572 1:STN:280:DyaK3M%2FnvFClsw%3D%3D (Pubitemid 20387332)
34. SM Nooyen BP Overbeek A Brutel de la Riviere AJ Storm JJ Langemeyer 1994 Prospective randomised comparison of single-dose versus multiple-dose cefuroxime for prophylaxis in coronary artery bypass grafting Eur J Clin Microbiol Infect Dis 13 1033 1037 7889965 1:STN:280:DyaK2M7ps1OrsQ%3D%3D
35. JD Scott A Forrest S Feuerstein P Fitzpatrick JJ Schentag 2001 Factors associated with postoperative infection Infect Control Hosp Epidemiol 22 347 351 11519911 1:STN:280:DC%2BD3Mvns1Cgtg%3D%3D (Pubitemid 32777034)